Manufacturers Life Insurance Company, The Mustang Bio, Inc. Transaction History

Manufacturers Life Insurance Company, The

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $15,717 - $30,621	-27,099 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$0.73 - $1.81 $19,782 - $49,049	27,099 New	27,099 $27,000
Q4 2021 Feb 16, 2022	SELL	$1.66 - $2.64 $1,826 - $2,904	-1,100 Reduced 3.9%	27,099 $45,000
Q3 2021 Nov 12, 2021	SELL	$2.58 - $3.36 $5,704 - $7,428	-2,211 Reduced 7.27%	28,199 $76,000
Q2 2021 Aug 12, 2021	BUY	$2.7 - $3.81 $13,721 - $19,362	5,082 Added 20.06%	30,410 $101,000
Q1 2021 May 03, 2021	SELL	$3.02 - $5.16 $38,936 - $66,527	-12,893 Reduced 33.73%	25,328 $84,000
Q4 2020 Feb 12, 2021	BUY	$2.66 - $4.18 $54,958 - $86,362	20,661 Added 117.66%	38,221 $145,000
Q3 2020 Nov 09, 2020	BUY	$3.01 - $3.88 $52,855 - $68,132	17,560 New	17,560 $55,000
Q1 2020 May 15, 2020	SELL	$1.91 - $4.52 $19,923 - $47,148	-10,431 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.57 - $4.08 $26,807 - $42,558	10,431 New	10,431 $43,000
Q3 2018 Nov 14, 2018	SELL	$5.71 - $7.58 $4,996 - $6,632	-875 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$10.14 - $12.38 $932 - $1,138	92 Added 11.75%	875 $10,000
Q4 2017 Feb 08, 2018	BUY	$8.75 - $11.99 $6,851 - $9,388	783	783 $9,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.